leadf
logo-loader
viewPhilip Morris International

Philip Morris and Altria’s mega tobacco merger goes up in smoke

Philip Morris, the maker of Marlboro cigarettes, said in August, discussions were ongoing for a possible all-stock merger of equals with Altria

Philip Morris International  - Philip Morris and Altria’s mega tobacco merger goes up in smoke
The companies now say they will focus on jointly launching a heated tobacco product called IQOS in the United States

Tobacco giants Phillip Morris International Inc (NYSE:PM) and Altria Group Inc (NYSE:MO) ended talks Wednesday to reunite the tobacco giants after more than a decade apart.

Investors responded well, sending shares of Philip Morris nearly 7.3% higher to $76.80 in morning trade. Altria stock also nearly climbed 2% to $41.42.

The companies, which said in late August that they were discussing a potential all-stock merger, now say they will focus on jointly launching IQOS, a tobacco vaporizer, in the United States. As of right now, it is the only product of its kind with pre-market authorization from the US Food and Drug Administration (FDA).

READ: Tobacco giants Philip Morris and Altria confirm talks over mega-merger

A merger would have reunited the two tobacco operations after they split in 2008. 

"While we believed the creation of a new merged company had the potential to create incremental revenue and cost synergies, we could not reach agreement," Altria CEO Howard Willard said in a statement.

"We look forward to continuing our commercialization of IQOS in the US under our existing arrangement," he added.

In a statement, Philip Morris CEO Andre Calantzopoulos echoed the same sentiments: “After much deliberation, the companies have agreed to focus on launching IQOS in the U.S. as part of their mutual interest to achieve a smoke-free future.”

Altria recently invested nearly $13 billion for a 35% stake in dominant global e-cigarette company Juul last year and has invested in cannabis company Cronos.

An outbreak of a mysterious lung disease has hit the vaping industry and has taken a bite out of Altria’s stock. The company has seen roughly $30 billion in market value erased since April when the FDA launched a new investigation into vaping.

Juul to replace CEO

In a separate announcement Wednesday, Juul which has been facing a public backlash, said former Altria executive KC Crosthwaite will replace Kevin Burns as chief executive officer. As Altria’s chief growth officer, Crosthwaite oversaw the company’s expansion into heated tobacco products.

Juul said Crosthwaite will continue “a broad review” of the company’s practices and policies to ensure alignment with its aim of responsible leadership.

More specifically, the company said it will suspend all broadcast, print and digital product advertising in the US. It also said it will not lobby the Trump administration on its impending policy to remove flavored e-cigarettes from the market. Federal survey data in 2018 showed teen vaping had snowballed into an “epidemic.”   

Contact Uttara Choudhury at [email protected]

Follow her on Twitter: @UttaraProactive 

Quick facts: Philip Morris International

Price: 74.86 USD

NYSE:PM
Market: NYSE
Market Cap: $116.58 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Market Report: FTSE gets an injection of optimism from US Remdesivir approval

FTSE 100 got a lift as a first treatment for COVID-19, remdesivir, was approved in the US. London’s leading index added 41 points to 5,826 in early dealings. Gilead Inc (NASDAQ:GILD) produces remdesivir and it is said to cut COVID-19 recovery times by five days. According to the World Health...

11 minutes ago

3 min read